2014, Volume 7, Issue 2, pp 291 – 295
Buga Corbu V
Glűck A **
Arion C **
* “Carol Davila" University of Medicine and Pharmacy, Bucharest
** “I. C. Fundeni" Pediatrics Clinic, “Carol Davila" University of Medicine and Pharmacy, Bucharest
Correspondence to:Buga Corbu Veronica, MD, PhD student “Carol Davila" University of Medicine and Pharmacy, Bucharest, 8 Eroilor Sanitari Blvd., 050474, Bucharest, Romania, Phone: +40 21 337 31 01
Abstract
Acute myeloblastic leukemia accounts for approximately 20% of acute leukemias in children. The days the microscope represented the main tool in the diagnosis and classification of Acute Myeloblastic Leukemia seem to be very far. This review summarizes the current diagnosis of this malignancy, where the morphological, cytochemical, immunophenotyping, cytogenetic and molecular characterization represents the basement of a risk group related therapy.
PMC ID: 4197485
PubMed ID: 25408742
DOI:
Article Publishing Date (print): 15-06-2014
Available Online: 25-06-2014
ISSN Printing: 1844-122X
ISSN Online: 1844-3117
Journal Title: Journal of Medicine and Life
Copyright License: Open Access
This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/
